Ferrous bisglycinate: absorption, side effects and how it compares with other forms of iron

Editorial illustration of a dark metallic sphere in a warmly lit circular niche, a visual metaphor for iron reserves.

Ferrous bisglycinate binds iron to two molecules of the amino acid glycine. It is often offered as a gentler alternative to conventional iron salts. That can matter if nausea or constipation makes it difficult to continue a necessary course of iron. The important questions remain the same: is there a reason to take iron, how much elemental iron does the product provide, and is treatment producing the expected response?

How ferrous bisglycinate is absorbed

How the chelate might enter the body

Conventional ferrous iron salts are absorbed in the upper small intestine through regulated transport systems, including a transporter called DMT1. Stomach acidity, food and existing iron stores all influence absorption. Researchers are investigating how far the chelate structure of bisglycinate protects iron from interactions in the gut, and whether other transport pathways contribute.

A completely separate route through amino acid and peptide transporters has not been clearly established. The systematic review mainly helps assess clinical differences between iron preparations. A favorable result with a lower amount does not, by itself, prove that absorption bypasses DMT1 altogether. The relative contribution of different pathways remains an open question.

Stability in the digestive tract

Binding iron to glycine can change the way it interacts with its surroundings. One proposed explanation for better tolerability is that less freely reactive iron remains inside the gut. How stable the compound stays, and which components are ultimately absorbed, depend on conditions along the digestive tract.

Being less affected by some dietary factors would not mean that food, calcium or medicines no longer matter. A long course of necessary treatment should follow appropriate instructions, rather than rely on a marketing claim that the product works entirely independently of meals.

Is its availability similar or better?

The meta-analysis found higher hemoglobin concentrations and fewer reported gastrointestinal adverse events in pregnant women taking bisglycinate than in those taking other oral iron preparations. It did not find significant differences in hemoglobin or ferritin among children. Differences in doses and populations make a universal conversion between products unreliable. A result from one pregnancy trial cannot tell us that everyone will replenish their stores equally well with an arbitrarily lower dose of bisglycinate.

A preparation that causes fewer symptoms may be easier to take consistently. That practical advantage can help treatment succeed, even when it does not establish universally better absorption.

How bisglycinate compares with other forms

Form	Understanding the iron content	What it means in practice
Ferrous sulfate	A common 325 mg preparation can provide about 65 mg of elemental iron; check the formulation	Well studied, with gastrointestinal side effects commonly reported
Ferrous bisglycinate	Products often provide 25–36 mg of elemental iron per serving	A possible alternative if another form causes problems; the actual label is what counts
Ferrous gluconate	Some 325 mg preparations provide about 36 mg of elemental iron	A lower iron proportion does not automatically mean fewer side effects when the elemental dose is the same
Ferric ammonium citrate	Iron content varies by product	Absorption and use depend on the formulation
Ferric pyrophosphate	Highly dependent on the formulation	A different compound from ferric maltol
Heme iron polypeptides	Product-dependent; derived from hemoglobin	A different source with its own evidence base, not automatically a better option for everyone

Accrufer contains ferric maltol, which should not be confused with ferric pyrophosphate. Nor can a single proposed lipid-mediated absorption route be attributed to every pyrophosphate product. These distinctions matter when comparing supplements with licensed medicines.

When bisglycinate may be an option

When ferrous sulfate is hard to tolerate

Nausea, abdominal pain and constipation can make iron difficult to take. Dark stools are common during iron treatment, but unusual tar-like stools, faintness or other signs of bleeding need medical assessment. Studies report different frequencies of side effects depending on the population, preparation and how symptoms are recorded; there is no single reliable percentage that applies to everyone taking sulfate.

Changing the form can be worth considering. The amount and dosing schedule also affect how manageable treatment is. Fewer symptoms on average in a study do not guarantee that bisglycinate will cause no problems for an individual.

When poor absorption is suspected

Acid-suppressing medicines, celiac disease and inflammatory bowel disease may be relevant when investigating why iron stores are low. Trials of different dosing schedules also show that the timing of oral iron can affect absorption, but they do not establish a solution for these conditions. A chelate does not automatically overcome every absorption problem or the effects of inflammation. If a correctly followed oral treatment is not working, the diagnosis, continuing blood loss and alternative treatment options need to be reconsidered.

During pregnancy and periods of greater need

Ferrous bisglycinate has been studied during pregnancy, when tolerability can be especially important. These trials do not replace an individual decision about preventing or treating deficiency. Any additional iron should be counted alongside the amount already supplied by a prenatal supplement.

Which measurements matter before and during treatment?

A full blood count, including hemoglobin and mean corpuscular volume (MCV, the average size of red blood cells), helps identify anemia and describe its features. Ferritin helps assess iron stores, but inflammation can raise it. In that setting, a normal or high ferritin result does not rule out every problem with iron availability.

Transferrin saturation, and sometimes transferrin or total iron-binding capacity, can provide further context. Serum iron alone varies with the time of day and recent iron intake, making it unreliable as the sole basis for a decision. The appropriate tests depend on the clinical question; repeated comprehensive iron panels are not necessary for everyone.

Finding the cause matters just as much. Blood loss, diet, pregnancy and impaired absorption can call for different approaches. Fatigue, cold hands or brittle nails alone do not prove iron deficiency. Equally, more iron is not always better: a review of iron and oxidative stress explains the biological risks of excess iron, rather than providing a diagnostic checklist for deficiency.

With effective treatment, hemoglobin can improve before iron stores are fully replenished. UK gastroenterology guidance recommends checking the hemoglobin response within the first four weeks and generally continuing treatment for about three months after it returns to normal. This is not a fixed timetable for ferritin to rise. The severity of deficiency, continuing losses, inflammation and absorption all affect progress. Follow-up should establish whether treatment is working and when it needs to be adjusted or stopped.

Frequently asked questions

Is bisglycinate better than sulfate?

It may be better tolerated in some groups, and trials have reported good results at lower elemental doses. Someone who tolerates sulfate and responds well to it does not necessarily need to switch. The evidence does not establish that bisglycinate is better for every person or purpose.

Can I take it with food?

Food can make iron easier to tolerate. It would be too strong to assume that meals have no effect on any chelated product, though. Follow the product instructions and the treatment plan agreed with your clinician.

How much elemental iron does it contain?

That depends on the product. The weight of the whole compound is different from the amount of iron itself. The often-quoted range of 25–36 mg is an example of serving sizes, not a fixed property of bisglycinate.

When will ferritin rise?

Measurements over several weeks can help show whether treatment is working, while fully replenishing stores often takes longer. If results are not changing as expected, the cause and treatment should be reassessed rather than simply increasing the amount on your own.

Can it cause constipation?

Yes. Better average tolerability does not rule out symptoms. Changes to the preparation, amount or schedule should still meet the needs of the iron treatment. Taking iron every other day is not a universal solution for everyone.

Is it suitable during pregnancy?

There are trials in pregnancy, and bisglycinate is used in prenatal products. The linked 2022 trial tested bisglycinate with folinic acid and other vitamins, so its results cannot be attributed to iron form alone. The amount needed depends on the situation and test results, rather than simply on a “gentle” label.

Does it interact with medicines?

Yes. Iron can affect the absorption of levothyroxine and certain antibiotics, among other medicines. A blanket two-hour gap is not sufficient for every drug; levothyroxine commonly requires a longer interval. A pharmacist or clinician can check the specific schedule. Additional high-dose vitamin C is not automatically necessary.

How do I know whether I need iron?

An appropriate assessment combines relevant tests with an investigation of the cause. Taking extra iron without a need can be harmful, particularly in people with iron overload. Keep iron preparations out of children’s reach: an accidental overdose can be dangerous.

Sources and review scope

Additional guidance on diagnosis, monitoring and treatment: British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. https://gut.bmj.com/content/70/11/2030

Background on iron status, supplement content and medicine interactions: NIH Office of Dietary Supplements, Iron: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/

Product identity: FDA prescribing information for ACCRUFER (ferric maltol). https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212320s019lbl.pdf